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Helicobacter pylori is known to be a major cause of peptic ulceration. The jhp0562 gene, encoding a glyco-
syltransferase involved in the synthesis of the lipopolysaccharide, was associated with peptic ulcer disease
(PUD) in children. The -(1,3)-galactosyltransferase [-(1,3)GalT] gene (jhp0563), involved in Lewis (Le)
antigen expression, is highly similar to jhp0562. The clinical significance and diversity of both genes were
examined by PCR and sequencing of clinical strains (n  117) isolated from children with PUD (n  57) and
nonulcer dyspepsia (NUD; n  60). The prevalence of the jhp0562 gene was significantly higher in strains with
a more-virulent profile (strains positive for the cag pathogenicity island [PAI], vacA sl allele, babA, homB,
phase-variable gene oipA “on” [i.e., functional], and hopQ I allele). The distribution of genotypes according to
clinical outcome showed that the presence of jhp0562 represented one of the greatest risks for the development
of PUD. Moreover, the triple-positive genotype for the cag PAI, jhp0562, and homB provided the best discrim-
inatory model for distinguishing PUD and NUD outcomes in children. Sequence and in vitro expression
analyses of jhp0562 showed the presence of a complete open reading frame, while the -(1,3)GalT gene was
shown to be a phase-variable gene. The regular presence of jhp0562 in strains with a truncated -(1,3)GalT
gene suggests that jhp0562 may also be implicated in the regulation of Le antigen expression. Overall, the
results of this study suggest that the jhp0562 gene is of great clinical relevance, being a useful comarker for
severe H. pylori-related disease and contributing to host adaptation.
Helicobacter pylori colonizes the human gastric mucus layer
and is the major causative agent of chronic active gastritis,
peptic ulcer disease (PUD), gastric carcinoma, and gastric mu-
cosa-associated lymphoid tissue (MALT) lymphoma (8, 16, 19,
28). Progression to diseases of greater severity occurs only in
certain infected individuals and seems to depend on a number
of factors, including host genetic susceptibility, environmental
factors, and differences in H. pylori strain virulence.
Comparison of H. pylori strains isolated from patients with
symptomatic gastric disease, such as gastric cancer or PUD,
with strains isolated from patients with no such history is useful
in identifying bacterial genetic markers associated with gastric
disease. Recently, the jhp0562 gene was isolated from a duo-
denal ulcer (DU)-associated strain, by means of PCR-based
subtractive hybridization, in which the genomic content of two
H. pylori strains isolated from two young children, one present-
ing with DU and the other with recurrent abdominal pain and
gastritis, was analyzed (27). The jhp0562 gene was found to be
highly associated with PUD in children (15 with PUD and 30
with nonulcer dyspepsia [NUD] with gastritis) (27). This gene
encodes a glycosyltransferase involved in the synthesis of the
chemical structure of the lipopolysaccharide (LPS). It is
present in the genome of the J99 strain but absent in the 26695
strain and located immediately upstream of the -(1,3)-galac-
tosyltransferase [-(1,3)GalT] gene (jhp0563 or HP0619 ac-
cording to the annotation of these strains), which in turn en-
codes a -(1,3)GalT involved in type I Lewis (Le) antigen (Lea
and Leb) synthesis of the LPS (3, 31). jhp0562 and the
-(1,3)GalT gene are highly similar (80%), especially at their
5 and 3 ends (2, 9).
The present study aimed to evaluate (i) the clinical relevance
of the jhp0562 gene by examining its association with H. pylori
virulence-associated genes and with clinical outcome as well as
(ii) the jhp0562 gene polymorphisms among clinical isolates,
including in vitro gene expression. Due to the high-level simi-
larity between jhp0562 and the -(1,3)GalT gene, the genetic
polymorphism of the latter was also studied. H. pylori strains
from a pediatric population were chosen, since children are by
definition recently colonized, therefore constituting a privi-
leged natural model with less interference of environmental
and age-related factors.
MATERIALS AND METHODS
Patients and H. pylori bacterial strains. A total of 117 H. pylori strains
isolated from children attending the three pediatric gastroenterology units in
the Lisbon area (Portugal) for upper gastrointestinal symptoms were exam-
ined in this study. These strains belong to the collection of H. pylori strains in
the Department of Infectious Diseases of the Instituto Nacional Sau´de Dr.
Ricardo Jorge, in Lisbon, Portugal. Fifty-seven children presented with PUD
(53 with DU and 4 with gastric ulcers), and 60 presented with abdominal pain
and gastritis only, categorized as NUD. The characteristics of the study
population are described in Table 1.
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Two H. pylori strains with sequenced genomes, 26695 (ATCC 700392), nega-
tive for jhp0562 and positive for the -(1,3)GalT gene, and J99 (ATCC 700824),
positive for both genes (Table 2), were used as control strains (2, 35).
All of the strains were cultured from antral biopsy specimens as previously
reported (20). In the case of possible mixed infections, all of the colonies were
recovered from the plate and used for the study. Genomic DNA was extracted
from a 48-h culture by using the QIAamp DNA minikit (Qiagen GmbH, Hilden,
Germany) and stored at 20°C until required for analysis.
Genotyping of jhp0562 and H. pylori virulence factors. The jhp0562 gene was
detected by PCR using a set of primers previously described (27), F1-jhp0562/
jhp0563 (5-TGAAAAGCCCTTTTGATTTTG-3), and R1-jhp0562/jhp0563 (5-G
CTGTAGTGGCCACATACACG-3). This PCR generates two PCR products with
301 and 602 bp in the J99 strain, corresponding to the jhp0562 and -(1,3)GalT
(jhp0563) genes, respectively, and only one PCR product with 558 bp in the 26695
strain, corresponding to the -(1,3)GalT gene (HP0619) (27). PCR fragments from
clinical strains presenting different sizes were identified by sequencing.
The characterization of the two major H. pylori virulence genes, the cag
pathogenicity island (PAI) (for which both cagA and cag empty site genotypes
were determined) and the vacA s region, was performed by PCR (1, 5, 36). The
status of H. pylori babA, homB, oipA, hopQ, sabA, and hopZ outer membrane
protein-encoding genes was determined by PCR and sequencing in some cases as
previously described (6, 12, 17, 27, 29, 40).
Diversity in jhp0562 and -(1,3)GalT genes. To study the diversity at the
jhp0562–-(1,3)GalT gene locus, as well as polymorphisms in the sequences of
these genes, PCR primers designed in the conserved genomic flanking open
reading frame (ORF) (jhp0561 and jhp0564, according to J99 strain annotation)
were used for the amplification of this locus (F1-jhp0561, 5-CATAACCGCAT
GCGGGTGTTT-3; R1-jhp0564, 5-CGCACAAAGAATCAGCGTCAT-3).
Sequencing of the PCR products was achieved on both strands by using the initial
set of PCR primers and highly specific internal primers F2-jhp0562 (5-CTACC
CATAAAGTCATCCACTA-3), R2-jhp0563 (5-AGGCAAACATCAAAGAG
AC-3), and R3-jhp0563 (5-TAACTTCATGATTTTCAATAGG-3).
Reverse transcription. RNA was extracted from a 48-h culture by using the
High Pure RNA isolation kit (Roche Diagnostics GmbH, Mannheim, Germany)
according to the manufacturer’s recommendations. Also, as recommended by the
manufacturer, a DNase I digestion step was performed to eliminate residual
genomic DNA. Reverse transcription reactions were carried out with 500 ng of
RNA by using the Transcriptor First Strand cDNA synthesis kit (Roche Diag-
nostics GmbH) according to the manufacturer’s instructions. The cDNA ob-
tained was then used as the template in PCRs using the F1-jhp0562/jhp0563–
R1-jhp0562/jhp0563 set of primers. In order to check the quality and integrity of
the RNA, a PCR targeting the 23S rRNA gene was performed in parallel (21).
The absence of DNA contamination in RNA preparations was controlled by
performing PCR without the reverse transcription step.
Statistical analysis. Statistical analysis was performed with the statistical pack-
age SPSS for Windows 17.0 (2008). Association between the genotypes was first
evaluated by the 2 and Fisher’s exact tests. Then, a principal-component anal-
ysis for categorical data was performed in order to measure the global associa-
tion of the genotypes studied. To confirm the results of the former analysis, a
cluster analysis was used to draw a dendrogram based on the same variables by
using the average aggregation method and Euclidian distance.
To identify possible associations between the H. pylori genotypes and clinical
outcome, a univariate analysis, using Fisher’s exact test, was performed. The
results were confirmed by unconditional binary logistic regression analysis.
Lastly, in order to evaluate which combinations of genotypes presented the most
discriminatory capacity to distinguish the clinical outcome, a binary logistic
TABLE 1. Distribution of the 117 H. pylori strains in the study by
clinical outcome, peptic ulcer disease or nonulcer dyspepsia,
patient gender, and patient age
Parameter
Value by clinical outcome
P value
PUD NUD
No. of strains 57a 60
% of male patients 55.0 68.4 0.183b
Median age  SD (yr) 12.02  3.6 9.27  3.15 0.001c
a Of the 57 cases of peptic ulcer disease, 53 were duodenal ulcers and the
remaining 4 were gastric ulcers.
b Determined by the 2 test.
c Determined by the Mann-Whitney test.
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regression analysis was performed, using the backward stepwise method based on
the likelihood ratio test. All of the tests performed were two-tailed, and the level
of significance was always set at 5%.
Nucleotide sequence accession numbers. Full sequences of the jhp0562 and
-(1,3)GalT genes from the 34 H. pylori clinical strains are available at GenBank
with the accession numbers EF648399, EF648401 to EF648403, and EF648416 to
EF648445.
RESULTS
Association of jhp0562 with other virulence genes. The PCR
using the F1-jhp0562/jhp0563–R1-jhp0562/jhp0563 primer set
yielded PCR amplicons for all of the 117 H. pylori clinical
strains tested. Thus, the relationships between the jhp0562
genes and the other virulence markers were assessed for all of
the strains. The jhp0562 gene was strongly associated with
positive genotypes for the cag PAI (P  0.001), vacA s1 allele
(P  0.001), babA (P  0.001), homB (P  0.007), phase-
variable gene oipA “on” (i.e., functional) (P  0.001), and the
hopQ I allele (P  0.014).
Global analysis of the H. pylori virulence factors. In order to
evaluate how the different genotypes were associated, a prin-
cipal-component analysis for categorical data was performed,
including all of the genotypes and also the clinical outcome
(Fig. 1A). The analysis was performed on 83 strains for which
complete data were available for all of the variables tested.
Indeed, 34 strains presented a multiple genotype regarding
hopQ alleles (presence of both hopQ I and II alleles), reflecting
results from other studies (6, 7), and were excluded. The first
two components accounted for 55% of the total information
(43% for the horizontal axis [component 1] and 12% for the
vertical axis [component 2]). Two main clusters were identified
on each side of the horizontal axis (Fig. 1). The first included
strains positive for jhp0562, the cag PAI, vacA s1 allele, babA,
homB, oipA “on,” and the hopQ I allele (group A). The second
cluster included strains positive for sabA and hopZ “on” status
(group B), although these two genotypes were more weakly
associated than the genotypes in group A. Two subclusters, one
including cag PAI and vacA s1 allele (A1) and the other com-
FIG. 1. Analysis of the association of Helicobacter pylori virulence factors between themselves and according to clinical outcome. Complete data
(for the cag PAI, vacA s1 allele, babA, homB, oipA and sabA status, and hopQ and hopZ alleles) were available for 83 H. pylori strains isolated from
children with peptic ulcer disease (n  41) and nonulcer dyspepsia (n  42). (A) Principal-component analysis plot. (B) Dendrogram constructed
using the average aggregation method and Euclidian distance.
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prised of the hopQ I allele and homB (A2), were also observed.
In the context of the correlation between genotypes and clin-
ical outcome, PUD was closely related to the genotypes in-
cluded in group A and particularly close to jhp0562. By con-
trast, the clinical outcome NUD was not tightly associated with
any genotype (Fig. 1).
The dendrogram drawn from the results of the cluster anal-
ysis confirmed the presence of the formally identified groups as
well as the close relatedness of jhp0562 to PUD (Fig. 1B).
Distribution of jhp0562 and other virulence genotypes ac-
cording to clinical outcome. The 117 H. pylori clinical strains
isolated from patients with PUD or NUD were examined for
the presence of the jhp0562 gene, as well as the H. pylori
virulence-associated cag PAI, vacA s1 allele, babA, homB,
oipA, hopQ, sabA, and hopZ genes, in order to assess which
genotypes were associated with disease. The results of the
binary logistic regression analysis are shown in Table 3. The
univariate analysis showed that PUD was strongly associated
with the presence of jhp0562 (P  0.001; odds ratio [OR],
9.14), the cag PAI (P  0.001; OR, 15.36), vacA s1 allele (P 
0.001; OR, 11.14), babA (P  0.001; OR, 6.81), homB (P 
0.001; OR, 4.52), oipA gene with “on” status (P  0.001; OR,
5.69), and the hopQ type I allele (P 0.008; OR, 3.55). On the
other hand, functional sabA and hopZ genes were more
prevalent among NUD strains, although the difference was
not statistically significant. After we adjusted for all of the
genotypes, only the cag PAI and jhp0562 remained associ-
ated with PUD, although homB was at the limit of statistical
significance (Table 3).
In order to evaluate which genotype combinations presented
the most discriminatory capacity to distinguish the clinical out-
come, a binary logistic regression analysis was performed. We
used the backward stepwise method, which selects a subset
among all of the genotypes that best predicts the clinical out-
come with a small but statistically significant number of vari-
ables. The resulting parsimonious model that discriminates
between PUD and NUD was the triple-positive genotype for
the cag PAI, jhp0562, and homB (Table 3). In fact, this com-
bination was present in 49.1% of the PUD-associated strains
and in only 11.9% of the NUD-associated strains (P  0.001;
OR, 7.17; 95% confidence interval [CI], 2.79 to 18.45).
Diversity in jhp0562 and -(1,3)GalT genes. With regard to
the currently available H. pylori complete genomes (n  10;
Table 2), a BLAST search revealed that the jhp0563-like ORF
is always present and only at the expected locus, and it seems
to be regulated by phase variation and rarely expressed in vitro.
Moreover, the tandem-repeat sequences (21 nucleotides [nt])
differ by up to seven repeats in those strains. The jhp0562-like
ORF, on the contrary, is not consistently present either at the
expected locus or at another locus.
Using the F1-jhp0562/jhp0563–R1-jhp0562/jhp0563 primer
set, PCR fragments corresponding to jhp0562, the -(1,3)GalT
gene, or both genes were detected in all of the H. pylori clinical
strains tested, indicating the constant presence of at least one
of these two genes. The fragment corresponding to jhp0562
presented a constant size of 301 bp, whereas the length of the
PCR product corresponding to the -(1,3)GalT gene ranged
from 535 to 675 bp, as confirmed by sequencing. Four different
combinations of these two genes were observed (Fig. 2): only
one PCR fragment, corresponding either to the jhp0562 gene
(profile 1) or to the -(1,3)GalT gene (profile 2), or two PCR
fragments, corresponding to each of the two genes (profile 3)
or corresponding to two -(1,3)GalT gene fragments of differ-
ent lengths (profile 4). Overall, the presence of both genes
(profile 3) was observed in 41.3% of the strains, the presence
of the -(1,3)GalT gene only (profile 2) was observed in 37.6%
of the isolates, and the presence of jhp0562 only (profile 1)
accounted for 17.5% of the strains, while the presence of two
-(1,3)GalT gene fragments of different lengths (profile 4) was
rare (3.6% of the strains). The distributions of the four profiles
differed markedly between the two disease groups (Table 4).
The presence of both genes was most prevalent in PUD-asso-
ciated strains (29/57, 50.9%), while the majority of NUD-as-
sociated strains harbored only the -(1,3)GalT gene (37/60,
61.7%). Furthermore, the presence of the jhp0562 gene alone
was observed in 19 of the 57 PUD-associated strains (33.3%)
but in only 1 NUD-associated strain (1.7%) (P  0.001). In-
versely, the presence of the -(1,3)GalT gene alone was sig-
nificantly more frequent in NUD-associated strains (37/60,
61.7%) than in PUD-associated strains (7/57, 12.3%) (P 
0.001).
In order to check the status of the jhp0562 and -(1,3)GalT
TABLE 3. Statistical analysis of the association between virulence-associated genes and clinical outcome in 117 H. pylori strains
Genotype
No. (%) of strains
associated with:
P valueb
OR (95% CI)
PUD
(n  57)
NUD
(n  60) Crude Adjusted
c Adjusted for final
modeld
jhp0562 48 (84.2) 21 (35.0) 0.001 9.14 (3.74–22.32) 6.55 (1.54–27.89) 5.82 (1.64–20.63)
cag PAI 43 (75.4) 10 (16.7) 0.001 15.36 (6.19–38.08) 6.68 (1.27–35.28) 5.58 (1.64–19.04)
vacA s1 40 (70.2) 11 (18.3) 0.001 11.14 (4.65–26.69) 0.94 (0.12–7.48) NI
babA 27 (47.4) 7 (11.7) 0.001 6.81 (2.65–17.52) 3.51 (0.63–19.71) NI
homB 41 (71.9) 21 (35.0) 0.001 4.52 (2.10–9.93) 4.68 (0.96–22.77) 3.43 (1.02–11.54)
oipA “on” 40 (70.2) 18 (30.0) 0.001 5.69 (2.55–12.69) 0.44 (0.07–2.75) NI
hopQ Ia 29 (70.7) 17 (40.5) 0.008 3.55 (1.43–8.85) 0.88 (0.16–4.96) NI
sabA “on” 25 (43.9) 34 (56.7) 0.197 0.60 (0.29–1.24) 0.79 (0.21–2.92) NI
hopZ “on” 36 (63.2) 39 (65.0) 0.85 0.92 (0.43–1.97) 2.3 (0.49–11.07) NI
a n  83; strains with multiple hopQ genotypes were excluded.
b P values were determined using Fisher’s exact test.
c Adjusted by logistic regression.
d Adjusted by binary logistic regression (final model determined by the backward stepwise method). NI, genotype not included in the final model.
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genes in H. pylori clinical strains, the jhp0562-jhp0563 locus
(according to the J99 strain annotation) was amplified and
sequenced. The -(1,3)GalT gene is a phase-variable gene and
is out of frame in most of the sequenced H. pylori strains, while
this kind of regulation is not observed for jhp0562, which, when
present, displays a complete coding sequence (Table 2). A total
of 34 clinical strains were analyzed at this locus: 8 strains with
jhp0562 only, 13 strains with the -(1,3)GalT gene only, and 13
strains carrying both genes. Amplification and sequencing re-
sults of these clinical strains showed that these genes occupy
the same region in the chromosome as in reference strains and
display similar genomic organizations, i.e., when the two genes
are present, the jhp0562 gene is always upstream of the
-(1,3)GalT gene. Among the strains analyzed, the jhp0562
gene had a constant length of 999 bp, except for two cases with
lengths of 993 and 1,002 bp, and the corresponding ORF was
always in frame. The -(1,3)GalT gene presented a variable
length (from 1,230 to 1,409 bp) due to a variation in the
number of 21-nt tandem-repeat previously reported sequences
(31–33), and 16 of the 26 (61.5%) sequences analyzed were out
of frame, due to the presence of homopolymeric tract of C
repeats (ranging from 8 to 15) in the middle region of the gene,
resulting in a nonsense frameshift mutation (31). Interestingly,
in the 13 strains in which the -(1,3)GalT gene was present
alone, 9 ORFs (69.2%) were in frame, whereas among the 13
isolates positive for both genes, 12 (92.3%) carried an out of
frame -(1,3)GalT gene.
Study of the in vitro transcripts of the jhp0562 and
-(1,3)GalT genes. The total RNAs from the sequenced 26695
and J99 strains as well as from the 34 clinical strains mentioned
above were reverse transcribed with random primers and then
used in a control PCR targeting the 23S rRNA gene and in a
PCR discriminating between jhp0562 and -(1,3)GalT genes.
First, the 23S rRNA gene transcript was observed for all of the
strains tested (not shown). With regard to the second PCR,
only the fragment corresponding to the jhp0562 gene was ob-
served for the J99 strain, and the expected PCR fragment
corresponding to the -(1,3)GalT gene was lacking. No reverse
transcription-PCR product corresponding to the -(1,3)GalT
gene was detected for strain 26695 (data not shown), whose
-(1,3)GalT gene is out of frame. With regard to clinical
strains, the jhp0562 gene was found to be expressed in all of the
21 strains positive for this gene, and the -(1,3)GalT gene was
expressed differently according to the frame status of the se-
quence, i.e., an absence of amplification for the 16 out-of-
frame sequences and an amplification for the 10 in-frame se-
quences.
DISCUSSION
Research over the past few years has led to the identification
of several H. pylori markers for severe gastric disease. This
study reports on the clinical relevance and diversity of the H.
pylori jhp0562 gene, encoding a protein from the cell envelope,
involved in the LPS biosynthesis, and recently associated with
PUD in children (27).
According to several statistical approaches, a positive geno-
type for jhp0562 was significantly more prevalent in strains with
a more-virulent profile, more specifically in strains carrying a
positive genotype for the cag PAI, vacA s1 allele, babA, homB,
oipA “on,” and the hopQ I allele, than in the less-virulent
strains. These results suggest that the jhp0562 gene could be a
good marker for H. pylori virulence. Moreover, when evaluat-
ing the distribution of H. pylori genotypes according to clinical
outcome, an increased risk for the development of PUD was
associated with strains carrying jhp0562, confirming previous
FIG. 2. jhp0562 and -(1,3)GalT gene profiles observed in Helicobacter pylori strains. The gene profiles were determined by PCR performed
on 117 Helicobacter pylori strains and amplicons were separated on a 1.5% agarose gel. MW, molecular weight marker X174 RF DNA/HaeIII
fragments (72 to 1,353 bp).
TABLE 4. Distribution of the jhp0562 and -(1,3)GalT genes by
clinical outcome among the 117 H. pylori strains studied
Copy no. of the genes according to the
size of PCR fragments (profile
designation)a
No. (%) of strains
associated with:
P valueb
PUD
(n  57)
NUD
(n  60)
Single copy of jhp0562 gene (1) 19 (33.3) 1 (1.7) 0.001
Single copy of the -(1,3)GalT
gene (2)
7 (12.3) 37 (61.7) 0.001
jhp0562 and -(1,3)GalT genes (3) 29 (50.9) 20 (33.3) NS
Two copies of the -(1,3)GalT
gene (4)
2 (3.5) 2 (3.3) NS
a According to lanes 1 to 4 of Fig. 1.
b P values were determined using Fisher’s exact test. NS, not statistically
significant.
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results obtained with a smaller group of strains (from 15 pa-
tients with PUD and 30 patients with NUD) (27). The cag PAI,
vacA s1 allele, babA, homB, oipA “on,” and hopQ I allele
genotypes were also independently associated with PUD.
However, the multivariate analysis showed that only the pres-
ence of the cag PAI and jhp0562 are significantly associated
with PUD. Finally, the triple-positive genotype for cag PAI,
jhp0562, and homB provided the best discriminatory model for
separating outcomes of PUD and NUD. Although these re-
sults were obtained with a small and select group of strains
which will require further validation, overall they suggest that
the jhp0562 gene can be a new comarker of PUD. It is impor-
tant to emphasize that the clinical strains used in the present
study were isolated from children, thus leading to a more
reliable model of the early natural conditions of the infection
and one that is less influenced by environmental determinants.
Several studies report that pediatric H. pylori strains display
more distinct virulence profiles than those isolated from adults
(13, 18, 25, 34). Accordingly, the severity of H. pylori-associated
disease in younger subjects may be closely related to the viru-
lence of the strain, independently of the host factors, which
may not be the case among adults. The fact that the results of
this study are in contrast with those from previous studies of
adults in the same geographic area, for which only cagA was
associated with PUD, is added proof (25, 26).
In the present study, jhp0562, the cag PAI, vacA s1 allele,
babA, homB, oipA “on,” and hopQ I were strongly associated
with each other. Similar findings have been previously reported
in other studies, excluding such results for jhp0562, whose
frequency was not determined (6, 10, 12, 25, 37, 40). Thus, the
coexpression of several genes most likely results from a shared
selective pressure, contributing to the fitness of the strains in
vivo. Therefore, the strong linkage of jhp0562 with PUD may
be due to its association with other virulence genes. One can
also speculate that all of these factors act synergistically in
causing damage to the host.
The jhp0562 gene is a strain-specific gene, located upstream
of the 80%-similar -(1,3)GalT gene (2, 24, 35). This genomic
organization was confirmed among H. pylori clinical isolates
presenting both of these genes. It was, however, observed that
the jhp0562–-(1,3)GalT gene locus could be occupied only by
the jhp0562 gene [the -(1,3)GalT gene being absent], and this
profile was significantly more prevalent among PUD-associ-
ated strains than among NUD-associated isolates (33.3% ver-
sus 1.7%, respectively). Interestingly, the occurrence of the
-(1,3)GalT gene locus alone was the most prevalent genotype
among NUD-associated strains, and this prevalence was sig-
nificantly higher than that observed among PUD-associated
strains (61% versus 12.3%, respectively). These observations
confirm the previously described association of jhp0562 with
PUD in children (27).
H. pylori expresses Le antigens in its LPS, both type I (Lea
and Leb) and type II (Lex and Ley), and they are structurally
related to the human blood group antigens also expressed in
gastric epithelial cells (22, 23). The exact role of these Le
antigenic structures during H. pylori infection is still unclear,
although their importance for bacterial colonization, adher-
ence, or evasion of host immune response has been hypothe-
sized (4, 11, 14, 39). A recent study reported that mutagenesis
of jhp0562 resulted in the loss of expression of all Le types,
suggesting that the product of this gene is truly an essential
glycosyltransferase for Le expression (30).
The -(1,3)GalT gene encodes a -(1,3)-galactosyltrans-
ferase involved in type I Le antigen synthesis (3, 31). Expres-
sion of this gene is regulated by a slipped-strand repair mech-
anism, while jhp0562 is a non-phase-variable homologue of the
-(1,3)GalT gene (2, 24, 31). A variation in the gene status was
confirmed for the -(1,3)GalT gene among the clinical strains
examined. Furthermore, studies of the in vitro expression of
the -(1,3)GalT gene showed that this gene was expressed
differently according to the frame status of the sequence, con-
firming its regulation by a slipped-strand repair mechanism.
The possibility of a translational control locus of Le gene
expression was also suggested for the -(1,3)GalT gene (31).
Interestingly, -(1,3)GalT functionality seemed to be related
to the presence or absence of the homologue gene jhp0562. In
fact, for 92.3% of the isolates harboring both genes, the
-(1,3)GalT gene was nonfunctional, while a complete corre-
sponding jhp0562 ORF was present. In contrast, in the absence
of jhp0562, only 33.3% of the isolates presented a truncated
-(1,3)GalT ORF. These results offer further support that the
products of the two genes have the same cell function and that
one product may functionally replace the other.
In vivo regulation of the -(1,3)GalT gene was initially ob-
served in the 21-nt tandem-repeat sequences which showed
length variation during colonization (32), and it was proposed
that this gene uses instability within simple sequence repeats as
a gene switching mechanism (33). Pohl et al. also showed that
the variation in the -(1,3)GalT gene homopolymeric tract
length affected Leb expression (31). More importantly, using a
Leb-expressing transgenic mouse model, they provided evi-
dence that H. pylori can change the Le phenotype to match the
Le phenotype of its host, supporting previous studies in hu-
mans and rhesus monkeys (31, 38, 39). The change to a type I
Le phenotype was found to be linked to a variation in the
-(1,3)GalT gene homopolymeric tract length, suggesting that
this locus is under host selection pressure (31). Moreover, the
possibility of recombination between the -(1,3)GalT gene and
its upstream homologue, jhp0562, was suggested (30). There-
fore, based on this and based on the results of the present
study, one can speculate that the presence of the jhp0562 gene
in strains with a truncated -(1,3)GalT may constitute an al-
ternative regulation mechanism for Le antigen expression in-
volved in host adaptation.
In conclusion, the strong correlation of jhp0562 with PUD
and with the main H. pylori-associated virulence markers sug-
gests that this gene is a good candidate as a virulence marker
of H. pylori. Moreover, the product of jhp0562, a glycosyltrans-
ferase, may be essential for the survival of the bacteria in vivo,
as it is most likely implicated in host adaptation, contributing
to the persistence of the infection.
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